These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 10718104)
1. Felodipine/metoprolol: a review of the fixed dose controlled release formulation in the management of essential hypertension. Haria M; Plosker GL; Markham A Drugs; 2000 Jan; 59(1):141-57. PubMed ID: 10718104 [TBL] [Abstract][Full Text] [Related]
2. The pharmacodynamic and pharmacokinetic profiles of controlled-release formulations of felodipine and metoprolol in free and fixed combinations in elderly hypertensive patients. McLay JS; MacDonald TM; Hosie J; Elliott HL; Eur J Clin Pharmacol; 2000 Nov; 56(8):529-35. PubMed ID: 11151741 [TBL] [Abstract][Full Text] [Related]
3. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate-Felodipine Antihypertension Combination Trial (M-FACT). Frishman WH; Hainer JW; Sugg J; Am J Hypertens; 2006 Apr; 19(4):388-95. PubMed ID: 16580575 [TBL] [Abstract][Full Text] [Related]
4. Improved efficacy with maintained tolerability in the treatment of primary hypertension. Comparison between the felodipine-metoprolol combination tablet and monotherapy with enalapril. Swedish Multicentre Group. Andersson OK J Hum Hypertens; 1999 Jan; 13(1):55-60. PubMed ID: 9928753 [TBL] [Abstract][Full Text] [Related]
5. Comparison of a felodipine-metoprolol combination tablet vs each component alone as antihypertensive therapy. The German Multicentre Study Group. Hoffmann J Blood Press Suppl; 1993; 1():30-6. PubMed ID: 8173688 [TBL] [Abstract][Full Text] [Related]
6. Antihypertensive efficacy and tolerability of a fixed combination of metoprolol and felodipine in comparison with the individual substances in monotherapy. The Swedish/United Kingdom Study Group. Dahlöf B; Hosie J J Cardiovasc Pharmacol; 1990 Dec; 16(6):910-6. PubMed ID: 1704983 [TBL] [Abstract][Full Text] [Related]
7. Ambulatory 24-h blood pressure assessment of the felodipine-metoprolol combination versus amlodipine in mild to moderate hypertension. Lorraine General Physician Investigators Group. Zannad F; Boivin JM J Hypertens; 1999 Jul; 17(7):1023-32. PubMed ID: 10419077 [TBL] [Abstract][Full Text] [Related]
8. Felodipine-metoprolol combination tablet: a valuable option to initiate antihypertensive therapy? Waeber B; Detry JM; Dahlöf B; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Safar M; Tanser P; Toutouzas P Am J Hypertens; 1999 Sep; 12(9 Pt 1):915-20. PubMed ID: 10509550 [TBL] [Abstract][Full Text] [Related]
9. Improved antihypertensive efficacy of the felodipine-metoprolol extended-release tablet compared with each drug alone. Dahlöf B; Jönsson L; Borgholst O; Ekblad G; Engstrand C; Grundestam I; Lindh A Blood Press Suppl; 1993; 1():37-45. PubMed ID: 8173689 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive efficacy and tolerability of a new once-daily felodipine-metoprolol combination compared with each component alone. The Swedish/UK Study Group. Dahlöf B; Hosie J Blood Press Suppl; 1993; 1():22-9. PubMed ID: 8173687 [TBL] [Abstract][Full Text] [Related]
11. Ramipril/felodipine extended-release fixed-dose combination: a review of its use in the management of essential hypertension. Cvetković RS; Plosker GL Drugs; 2005; 65(13):1851-68. PubMed ID: 16114982 [TBL] [Abstract][Full Text] [Related]
12. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction. Dahlöf B; Degl' Innocenti A; Elmfeldt D; Puig JG; Gundersen T; Hosie J; Januszewicz W; Lindström CJ; Magometschnigg D; Tanser P; Toutouzas P; Waeber B; Wiklund I Am J Hypertens; 2005 Oct; 18(10):1313-9. PubMed ID: 16202854 [TBL] [Abstract][Full Text] [Related]
13. Comparison of two strategies for intensifying antihypertensive treatment: low-dose combination (enalapril + felodipine ER) versus increased dose of monotherapy (enalapril). LEVEL (Lexxel vs Enalapril) Study Group. Elliott WJ; Montoro R; Smith D; Leibowitz M; Hwang C; Gradman AH; Schleman M; Klibaner M Am J Hypertens; 1999 Jul; 12(7):691-6. PubMed ID: 10411366 [TBL] [Abstract][Full Text] [Related]
14. A double-blind comparison of felodipine and hydrochlorothiazide added to metoprolol to control hypertension. Groom P; Simpson RJ; Singh B; Ward DE; Peers E; Richardson PD Eur J Clin Pharmacol; 1988; 34(1):21-4. PubMed ID: 3282893 [TBL] [Abstract][Full Text] [Related]
15. Long-term efficacy, tolerability, and safety of the combination of enalapril and felodipine ER in the treatment of hypertension. Enalapril-Felodipine ER Factorial Study Group. Gradman AH; Cutler NR; Davis PJ; Robbins JA; Weiss RJ; Wood BC; Michelson EL Clin Ther; 1998; 20(3):527-38. PubMed ID: 9663368 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic comparisons of enalapril and felodipine and their combination. Morgan TO; Anderson A Kidney Int Suppl; 1992 May; 36():S78-81. PubMed ID: 1614072 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy, safety and tolerance of Felodipine controlled release tablets and Felodipine controlled release tablets associated combination therapy in the treatment of mild to moderate essential hypertension in China]. Chen YY; Sun NL; Zhang WZ; Wu HY; Zhang L; Yu ZQ; Zhang FC; Xiang XP; Liu HL; Shen FR; Tao J; Zhao JA Beijing Da Xue Xue Bao Yi Xue Ban; 2007 Dec; 39(6):619-23. PubMed ID: 18087554 [TBL] [Abstract][Full Text] [Related]
18. Manidipine: a review of its use in hypertension. Cheer SM; McClellan K Drugs; 2001; 61(12):1777-99. PubMed ID: 11693466 [TBL] [Abstract][Full Text] [Related]
19. Improving the therapeutic balance between efficacy and tolerability in antihypertensive drugs--the rationale and benefits of combining felodipine and metoprolol. Trenkwalder P; Elmfeldt D J Hum Hypertens; 1995 Jul; 9 Suppl 2():S37-42. PubMed ID: 7562898 [TBL] [Abstract][Full Text] [Related]
20. Fixed-dose combination enalapril/nitrendipine: a review of its use in mild-to-moderate hypertension. Siddiqui MA; Plosker GL Drugs; 2004; 64(10):1135-48. PubMed ID: 15139792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]